ADHERENCE TO TRIPLE THERAPY IN HCV

被引：0
|
作者：
Morisco, F. [1 ]
Di Costanzo, G. G. [2 ]
Camera, S. [1 ]
Guarino, M. [1 ]
Clery, E. [1 ]
Ferraiuoli, C. [1 ]
Granata, R. [1 ]
Loperto, I. [1 ]
Cossiga, V. [1 ]
Lampasi, F. [2 ]
Tartaglione, M. T. [2 ]
Caporaso, N. [1 ]
机构：
[1] Univ Naples Federico II, Gastroenterol Units, Dept Clin Med & Surg, Naples, Italy
[2] Cardarelli Hosp, Liver Unit, Naples, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2014年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P.17.10
引用
收藏
页码：S123 / S124
页数：2
相关论文
共 50 条
  • [41] HCV direct-acting antiviral therapy adherence in people who inject drugs
    Jordan Hindson
    Nature Reviews Gastroenterology & Hepatology, 2024, 21 : 141 - 141
  • [42] SUBSTANTIAL RENAL IMPAIRMENT IS NOT INFREQUENT IN HCV PATIENTS UNDER TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR
    Mauss, S.
    Eisenbach, C.
    Moeller, B.
    Moog, G.
    Lutz, T.
    Naumann, U.
    Geissler, M.
    Kroeger, T.
    Mordeja, M.
    Herold, C.
    Simon, K. -G.
    Felten, G.
    Milicic-Ouakili, K.
    Buggisch, P.
    Hueppe, D.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S358 - S358
  • [43] FACTORS ASSOCIATED WITH FAILURE OF TELAPREVIR- AND BOCEPREVIR-BASED HCV TRIPLE THERAPY
    Bichoupan, K.
    Tandon, N.
    Martel-Laferriere, V
    Sachs, D.
    Ng, M.
    Schonfeld, E. A.
    Pappas, A.
    Crismale, J.
    Stivala, A.
    Khaitova, V
    Gardenier, D.
    Linderman, M.
    Olson, W.
    Perumalswami, P.
    Schiano, T. D.
    Odin, J. A.
    Liu, L. U.
    Dieterich, D. T.
    Branch, A. D.
    VALUE IN HEALTH, 2014, 17 (03) : A265 - A265
  • [44] CORRELATION BETWEEN NK CELLS AND RESPONSE TO TRIPLE HCV-THERAPY WITH BOC/TVR
    Marenco, S.
    Pieri, G.
    Mazza, F.
    Brunacci, M.
    Labanca, S.
    Bruzzone, L.
    Valentina, F.
    Bozzano, F.
    Marras, F.
    De Maria, A.
    Savarino, V.
    Picciotto, A.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E66 - E66
  • [45] Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy
    Deneke, M. G.
    Dranoff, J. A.
    Duarte-Rojo, A.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2014, 79 (01): : 64 - 66
  • [46] Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir
    Mauss, Stefan
    Eisenbach, Christoph
    Heyne, Renate
    Moog, Gero
    Lutz, Thomas
    Naumann, Uwe
    Geissler, Michael
    Mordeja, Matthias
    Herold, Christoph
    Simon, Karl Georg
    Milicic-Ouakili, Kerstin
    Buggisch, Peter
    Hueppe, Dietrich
    GASTROENTEROLOGY, 2013, 144 (05) : S960 - S960
  • [47] Practical management of HCV genotype 1a in B thalassemia major with triple therapy
    Minor, M.
    Harmatz, P.
    Fuentebella, J.
    Haines, D.
    Lal, A.
    Vichinsky, E.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 : 10 - 10
  • [48] APLASTIC ANEMIA DURING TRIPLE THERAPY (TT) IN PATIENTS WITH HCV-RELATED CIRRHOSIS
    Lens, S.
    Calleja, J. L.
    Campillo, A.
    Banos, I.
    de la Revilla, J.
    Sanchez-Tapias, J. M.
    Forns, X.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S467 - S467
  • [49] Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis
    Federico, Alessandro
    Sgambato, Dolores
    Cotticelli, Gaetano
    Gravina, Antonietta Gerarda
    Dallio, Marcello
    Beneduce, Filippo
    Ruocco, Eleonora
    Romano, Marco
    Loguercio, Carmela
    HEPATITIS MONTHLY, 2014, 14 (03)
  • [50] Triple or dual therapy for HCV-1 naive patients? Optimizing selection tools
    Boglione, Lucio
    De Nicolo, Amedeo
    Di Perri, Giovanni
    D'Avolio, Antonio
    JOURNAL OF HEPATOLOGY, 2014, 61 (01) : 178 - 179
12345